Save your place

Sign in to WhoBought

Please try again later.

Praxis Precision Medicines, Inc. (PRAX) institutional ownership

Latest close $315.80 Jul 27, 2026
Market cap$1.1B 52-week range SectorHealthcare
Funds holding · Q1 2024
2
reported PRAX position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2024
Activity unavailable N/A
0 buyers · 2 sellers

Praxis Precision Medicines, Inc. (PRAX) price and institutional activity

Dates

Q1 2024

$0 bought by 0 investors
$0 sold by 2 investors
Sphera Funds Management Ltd.Baker Bros. Advisors LP
Bought Sold Totals per quarter; hover a bar for the names.

Praxis Precision Medicines, Inc. (PRAX) institutional activity · 2

Investor Type Est. change Change Δ Own Date
Sphera Funds Management Ltd. · Exited
Change −329K Δ Own −100.0% Date Q1 2024
Sphera Funds Management Ltd. Exited· Q1 2024 −329K −100.0% Q1 2024
Baker Bros. Advisors LP · Exited
Change −132K Δ Own −100.0% Date Q1 2024
Baker Bros. Advisors LP Exited· Q1 2024 −132K −100.0% Q1 2024
Data through Q1 2024 · filed Q1 2024
2 of 2

Famous investor activity in Praxis Precision Medicines, Inc. (PRAX)

Praxis Precision Medicines, Inc. (PRAX) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Souza Marcio · Director 2 operations -23K
Owned 0 Trade date Jul 8, 2026 Filed date Jul 8, 2026
Souza Marcio Director 2 operations -23K 0 Jul 8, 2026 Jul 8, 2026
Desimone Jill · Director 12 operations −$3.6M
Price $301.44–$315.70 Qty −12K Owned 2K ΔOwn −83.2% Trade date Jun 24, 2026 Filed date Jun 26, 2026
Desimone Jill Director 12 operations $301.44–$315.70 −12K −$3.6M 2K −83.2% Jun 24, 2026 Jun 26, 2026
Desimone Jill · Director 4 operations 0
Price $44.25–$147.30 Owned 0 Trade date Jun 24, 2026 Filed date Jun 26, 2026
Desimone Jill Director 4 operations $44.25–$147.30 0 0 Jun 24, 2026 Jun 26, 2026
Arbuckle Stuart A. · Director 2 operations 2K
Owned 648 Trade date Jun 10, 2026 Filed date Jun 12, 2026
Arbuckle Stuart A. Director 2 operations 2K 648 Jun 10, 2026 Jun 12, 2026
Chodakewitz Jeffrey · Director 2 operations 2K
Owned 648 Trade date Jun 10, 2026 Filed date Jun 12, 2026
Chodakewitz Jeffrey Director 2 operations 2K 648 Jun 10, 2026 Jun 12, 2026
Young William D. · Director 2 operations 2K
Owned 648 Trade date Jun 10, 2026 Filed date Jun 12, 2026
Young William D. Director 2 operations 2K 648 Jun 10, 2026 Jun 12, 2026
Desimone Jill · Director 2 operations 2K
Owned 648 Trade date Jun 10, 2026 Filed date Jun 12, 2026
Desimone Jill Director 2 operations 2K 648 Jun 10, 2026 Jun 12, 2026
Cudkowicz Merit Ester · Director 2 operations 2K
Owned 648 Trade date Jun 10, 2026 Filed date Jun 12, 2026
Cudkowicz Merit Ester Director 2 operations 2K 648 Jun 10, 2026 Jun 12, 2026
Mitchell Dean J. · Director 2 operations 2K
Owned 648 Trade date Jun 10, 2026 Filed date Jun 12, 2026
Mitchell Dean J. Director 2 operations 2K 648 Jun 10, 2026 Jun 12, 2026
Kindler Jeffrey B. · Director 2 operations 2K
Owned 648 Trade date Jun 10, 2026 Filed date Jun 12, 2026
Kindler Jeffrey B. Director 2 operations 2K 648 Jun 10, 2026 Jun 12, 2026
Norden Gregory · Director 2 operations 2K
Owned 648 Trade date Jun 10, 2026 Filed date Jun 12, 2026
Norden Gregory Director 2 operations 2K 648 Jun 10, 2026 Jun 12, 2026
Mastrocola Lauren · Officer Grant (A) $21K
Price $167.94 Qty 127 Owned 14K Trade date May 14, 2026 Filed date May 19, 2026
Mastrocola Lauren Officer Grant (A) $167.94 127 $21K 14K May 14, 2026 May 19, 2026
Nemiroff Alex · Officer Grant (A) $13K
Price $167.94 Qty 78 Owned 26K Trade date May 14, 2026 Filed date May 19, 2026
Nemiroff Alex Officer Grant (A) $167.94 78 $13K 26K May 14, 2026 May 19, 2026
Kelly Timothy Edwin · CFO Grant (A) $20K
Price $167.94 Qty 121 Owned 31K Trade date May 14, 2026 Filed date May 19, 2026
Kelly Timothy Edwin CFO Grant (A) $167.94 121 $20K 31K May 14, 2026 May 19, 2026
Sniecinski Megan · Officer Grant (A) $15K
Price $167.94 Qty 89 Owned 29K Trade date May 14, 2026 Filed date May 19, 2026
Sniecinski Megan Officer Grant (A) $167.94 89 $15K 29K May 14, 2026 May 19, 2026
15 of 44
15 of 44 Sign in to continue to older insider transactions.

Praxis Precision Medicines, Inc. (PRAX) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Orbis Investment Management Ltd 2.5M
% of shares outstanding 8.9% Filing date May 15, 2026
Orbis Investment Management Ltd 2.5M 8.9% May 15, 2026
FMR LLC 2.2M
% of shares outstanding 7.7% Filing date May 6, 2026
FMR LLC 2.2M 7.7% May 6, 2026
Baker Bros. Advisors LP 1.8M
% of shares outstanding 6.3% Filing date May 15, 2026
Baker Bros. Advisors LP 1.8M 6.3% May 15, 2026
Vanguard Capital Management 1.4M
% of shares outstanding 5.1% Filing date Apr 30, 2026
Vanguard Capital Management 1.4M 5.1% Apr 30, 2026
Venrock Healthcare Capital Partners Iii, L.P. 906K
% of shares outstanding 5.0% Filing date Nov 14, 2024
Venrock Healthcare Capital Partners Iii, L.P. 906K 5.0% Nov 14, 2024
Cormorant Asset Management, LP
% of shares outstanding 4.7% Filing date Nov 14, 2024
Cormorant Asset Management, LP 4.7% Nov 14, 2024
Point72 Asset Management, L.P. 0
% of shares outstanding 0.0% Filing date May 15, 2026
Point72 Asset Management, L.P. 0 0.0% May 15, 2026
7 of 7

Praxis Precision Medicines, Inc. (PRAX) ownership FAQ

Who owns PRAX?

2 reporting institutions disclosed PRAX position changes in the Q1 2024 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2024.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.